Linked Life Data

12760861

Source:http://linkedlifedata.com/resource/pubmed/id/12760861

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12760861rdf:typepubmed:Citationlld:pubmed
pubmed-article:12760861lifeskim:mentionsumls-concept:C0029235lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C0521346lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C0018483lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C0006132lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C0282335lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C1456627lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C0370215lld:lifeskim
pubmed-article:12760861lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:12760861pubmed:issue6lld:pubmed
pubmed-article:12760861pubmed:dateCreated2003-5-22lld:pubmed
pubmed-article:12760861pubmed:abstractTextA total of 7,566 unique patient isolates of Haemophilus influenzae and 2,314 unique patient isolates of Moraxella catarrhalis were collected between October 1997 and June 2002 from 25 medical centers in 9 of the 10 Canadian provinces. Among the 7,566 H. influenzae isolates, 22.5% produced beta-lactamase, while 92.4% of the 2,314 M. catarrhalis isolates produced beta-lactamase. The incidence of beta-lactamase-producing H. influenzae isolates decreased significantly over the 5-year study period, from 24.2% in 1997-1998 to 18.6% in 2001-2002 (P < 0.01). The incidence of beta-lactamase-producing M. catarrhalis isolates did not change over the study period. The overall rates of resistance to amoxicillin and amoxicillin-clavulanate for H. influenzae were 19.3 and 0.1%, respectively. The rank order of cephalosporin activity based on the MICs at which 90% of isolates were inhibited (MIC(90)s) was cefotaxime > cefixime > cefuroxime > cefprozil > cefaclor. On the basis of the MICs, azithromycin was more active than clarithromycin (14-OH clarithromycin was not tested); however, on the basis of the NCCLS breakpoints, resistance rates were 2.1 and 1.6%, respectively. Rates of resistance to other agents were as follows: doxycycline, 1.5%; trimethoprim-sulfamethoxazole, 14.2%; and chloramphenicol, 0.2%. All fluoroquinolones tested, including the investigational fluoroquinolones BMS284756 (garenoxacin) and ABT-492, displayed potent activities against H. influenzae, with MIC(90)s of < or = 0.03 microg/ml. The MIC(90)s of the investigational ketolides telithromycin and ABT-773 were 2 and 4 microg/ml, respectively, and the MIC(90) of the investigational glycylcycline GAR-936 (tigecycline) was 4 microg/ml. Among the M. catarrhalis isolates tested, the resistance rates derived by using the NCCLS breakpoint criteria for H. influenzae were <1% for all antibiotics tested except trimethoprim-sulfamethoxazole (1.5%). In summary, the incidence of beta-lactamase-positive H. influenzae strains in Canada is decreasing (18.6% in 2001-2002), while the incidence of beta-lactamase-positive M. catarrhalis strains has remained constant (90.0% in 2001-2002).lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:languageenglld:pubmed
pubmed-article:12760861pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:citationSubsetIMlld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12760861pubmed:statusMEDLINElld:pubmed
pubmed-article:12760861pubmed:monthJunlld:pubmed
pubmed-article:12760861pubmed:issn0066-4804lld:pubmed
pubmed-article:12760861pubmed:authorpubmed-author:ZhanelGeorge...lld:pubmed
pubmed-article:12760861pubmed:authorpubmed-author:HobanDaryl...lld:pubmed
pubmed-article:12760861pubmed:authorpubmed-author:NicholKimberl...lld:pubmed
pubmed-article:12760861pubmed:authorpubmed-author:PalatnickLorr...lld:pubmed
pubmed-article:12760861pubmed:authorpubmed-author:LowDon EDElld:pubmed
pubmed-article:12760861pubmed:authorpubmed-author:CROSS Study...lld:pubmed
pubmed-article:12760861pubmed:issnTypePrintlld:pubmed
pubmed-article:12760861pubmed:volume47lld:pubmed
pubmed-article:12760861pubmed:ownerNLMlld:pubmed
pubmed-article:12760861pubmed:authorsCompleteYlld:pubmed
pubmed-article:12760861pubmed:pagination1875-81lld:pubmed
pubmed-article:12760861pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:meshHeadingpubmed-meshheading:12760861...lld:pubmed
pubmed-article:12760861pubmed:year2003lld:pubmed
pubmed-article:12760861pubmed:articleTitleAntimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.lld:pubmed
pubmed-article:12760861pubmed:affiliationDepartment of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.lld:pubmed
pubmed-article:12760861pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12760861pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12760861lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12760861lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12760861lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12760861lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12760861lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12760861lld:pubmed